Asenapine-induced restless legs syndrome: differentiation from akathisia
- PMID: 25325577
- PMCID: PMC4237529
- DOI: 10.5664/jcsm.4296
Asenapine-induced restless legs syndrome: differentiation from akathisia
Abstract
Akathisia and restless legs syndrome (RLS) share some common clinical features and a common relationship with dopamine dysfunction. However, the underlying causes and appropriate treatments for akathisia and RLS are different. Herein we describe a case of RLS that was precipitated by a single dose of asenapine, which is an atypical antipsychotic, and dissect the features that support the contention that this was indeed a case of RLS and not akathisia.
Keywords: akathisia; asenapine; restless leg syndrome.
© 2014 American Academy of Sleep Medicine.
References
-
- Allen R, Picchietti D, Hening WA, et al. Restless legs syndrome: diagnostic criteria, special considerations, and epidemiology: a report from the restless legs syndrome diagnosis and epidemiology workshop at the National Institutes of Health. Sleep Med. 2003;4:101–19. - PubMed
-
- Cervenka S, Palhagen S, Comley RA, et al. Support for dopaminergic hypoactivity in restless legs syndrome: a PET study on D2-receptor binding. Brain. 2006;129:2017–28. - PubMed
-
- American Psychiatric Association. 5th ed. Arlington, VA: American Psychiatric Association; 2013. Diagnostic and Statistical Manual of Mental Disorders.
-
- Kumar R, Sachdev PS. Akathisia and second-generation antipsychotic drugs. Curr Opin Psychiatry. 2009;22:293–9. - PubMed
-
- Benes H, Walters AS, Allen RP, et al. Definition of restless legs syndrome, how to diagnose it, and how to differentiate it from RLS mimics. Mov Disord. 2007;22:S401–8. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
